INMD
Companies
NASDAQ
InMode Ltd.
Health Care
$13.34
-$3.36 (-20.12%)
Price Chart
Overview
About INMD
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.
Market Cap
$1.5B
Volume
13.5M
Avg. Volume
20.3M
P/E Ratio
6.9622645
Dividend Yield
0.00%
Employees
503.0
Company Information
Latest News for INMD
Risk & Correlation Analysis
Market Correlation
1.23
Moderate Correlation
Volatility
High (0.43)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, INMD shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.5B
Volume13.5M
P/E Ratio6.96
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
April 28, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025